Blood cell ratios and knee osteoarthritis treatment response
Part of Bones, joints & muscles clinical trials.
This study looks at whether certain blood cell ratios can predict how well a knee osteoarthritis treatment called platelet-rich plasma (PRP) works. PRP is made from your own blood and injected into the knee to help reduce pain and improve function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 60 years old.
- You have knee osteoarthritis that is grade 2 or 3 on an X-ray.
- Your body mass index (BMI) is below 40.
- You are scheduled to receive platelet-rich plasma (PRP) injections in your knee.
- You can attend follow-up visits for 6 months.
- You do not have inflammatory or autoimmune diseases, active infections, or are not on blood thinners or chemotherapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether platelet-rich plasma (a treatment made from your own blood) can reduce symptoms of knee osteoarthritis. It focuses on people with specific types of knee pain and X-ray findings, and compares against rules around current pain medicines and injections.
This study tests whether two types of platelet-rich plasma (a treatment made from your own blood) can help relieve severe knee osteoarthritis pain when injected into the bone and joint. It may offer a non-surgical option for people whose knee pain limits walking.
This trial tests using your own platelet-rich plasma (PRP), made from a blood sample, as an injection to treat knee osteoarthritis in active young adults. The goal is to see if it reduces pain and helps you stay active.
This trial tests a joint treatment made from your own platelets (platelet-rich plasma, or PRP) combined with other biologic material (from fat tissue and/or bone marrow) to help osteoarthritis symptoms. It may be an option if you have early-to-moderate osteoarthritis in a major joint and meet safety requirements.
This trial tests whether a combination of platelet-rich plasma (a concentrate from your own blood) and hyaluronic acid (a joint lubricant) helps reduce pain and improve function in people with knee arthritis. You may be eligible if you have moderate knee pain but your other knee is relatively pain-free.
This trial tests whether a platelet-rich plasma (PRP) shot works better than a standard hyaluronic acid (“gel”) injection to reduce knee osteoarthritis pain. It may help people with ongoing knee pain choose the treatment that relieves symptoms more effectively.
Hear when a new Knee Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.